Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Gastric Cancer

  Free Subscription


Articles published in J Clin Oncol

Retrieve available abstracts of 16 articles:
HTML format



Single Articles


    March 2021
  1. HAFFNER I, Schierle K, Raimundez E, Geier B, et al
    HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ Study.
    J Clin Oncol. 2021 Mar 25:JCO2002761. doi: 10.1200/JCO.20.02761.
    PubMed     Abstract available


    November 2020
  2. MOEHLER M, Dvorkin M, Boku N, Ozguroglu M, et al
    Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100.
    J Clin Oncol. 2020 Nov 16:JCO2000892. doi: 10.1200/JCO.20.00892.
    PubMed     Abstract available


    August 2020
  3. HYUNG WJ, Yang HK, Park YK, Lee HJ, et al
    Long-Term Outcomes of Laparoscopic Distal Gastrectomy for Locally Advanced Gastric Cancer: The KLASS-02-RCT Randomized Clinical Trial.
    J Clin Oncol. 2020 Aug 20:JCO2001210. doi: 10.1200/JCO.20.01210.
    PubMed     Abstract available


    July 2020
  4. CATENACCI DVT, Rasco D, Lee J, Rha SY, et al
    Phase I Escalation and Expansion Study of Bemarituzumab (FPA144) in Patients With Advanced Solid Tumors and FGFR2b-Selected Gastroesophageal Adenocarcinoma.
    J Clin Oncol. 2020;38:2418-2426.
    PubMed     Abstract available


    June 2020
  5. MAKIYAMA A, Sukawa Y, Kashiwada T, Kawada J, et al
    Randomized, Phase II Study of Trastuzumab Beyond Progression in Patients With HER2-Positive Advanced Gastric or Gastroesophageal Junction Cancer: WJOG7112G (T-ACT Study).
    J Clin Oncol. 2020;38:1919-1927.
    PubMed     Abstract available


    April 2020
  6. FUKUOKA S, Hara H, Takahashi N, Kojima T, et al
    Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603).
    J Clin Oncol. 2020 Apr 28:JCO1903296. doi: 10.1200/JCO.19.03296.
    PubMed     Abstract available


    February 2020
  7. IQBAL S, McDonough S, Lenz HJ, Ilson D, et al
    Randomized, Phase II Study Prospectively Evaluating Treatment of Metastatic Esophageal, Gastric, or Gastroesophageal Cancer by Gene Expression of ERCC1: SWOG S1201.
    J Clin Oncol. 2020;38:472-479.
    PubMed     Abstract available


    September 2019
  8. PIETRANTONIO F, Miceli R, Raimondi A, Kim YW, et al
    Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer.
    J Clin Oncol. 2019 Sep 12:JCO1901124. doi: 10.1200/JCO.19.01124.
    PubMed     Abstract available


    May 2019
  9. BONNOT PE, Piessen G, Kepenekian V, Decullier E, et al
    Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis.
    J Clin Oncol. 2019 May 14:JCO1801688. doi: 10.1200/JCO.18.01688.
    PubMed     Abstract available


    March 2019
  10. YOSHIDA K, Kodera Y, Kochi M, Ichikawa W, et al
    Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial.
    J Clin Oncol. 2019 Mar 29:JCO1801138. doi: 10.1200/JCO.18.01138.
    PubMed     Abstract available


    May 2018
  11. ISHIGAMI H, Fujiwara Y, Fukushima R, Nashimoto A, et al
    Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial.
    J Clin Oncol. 2018 May 10:JCO2018778613. doi: 10.1200/JCO.2018.77.8613.
    PubMed     Abstract available


    February 2018
  12. FORNARO L, Scartozzi M, Aprile G
    CALGB 80101 and the Final Call for Preoperative Chemotherapy in Gastric Cancer.
    J Clin Oncol. 2018 Feb 28:JCO2017766493. doi: 10.1200/JCO.2017.76.6493.
    PubMed    


    October 2017
  13. FUCHS CS, Niedzwiecki D, Mamon HJ, Tepper JE, et al
    Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance).
    J Clin Oncol. 2017 Oct 4:JCO2017742130. doi: 10.1200/JCO.2017.74.2130.
    PubMed     Abstract available


    August 2017
  14. SHAH MA, Xu RH, Bang YJ, Hoff PM, et al
    HELOISE: Phase IIIb Randomized Multicenter Study Comparing Standard-of-Care and Higher-Dose Trastuzumab Regimens Combined With Chemotherapy as First-Line Therapy in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Gastric or
    J Clin Oncol. 2017;35:2558-2567.
    PubMed     Abstract available


    February 2017
  15. BARTLEY AN, Washington MK, Colasacco C, Ventura CB, et al
    HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology.
    J Clin Oncol. 2017;35:446-464.
    PubMed     Abstract available


    May 2016
  16. LI J, Qin S, Xu J, Xiong J, et al
    Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction.
    J Clin Oncol. 2016;34:1448-54.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: